文献速递乳腺MR

一种用于鉴别已知乳腺癌患者MRI检出「二次查看」乳腺病灶良恶性的新评分系统

A new scoring system for differentiating malignant from benign "second-look" breast lesions detected by MRI in patients with known breast cancer.
PubMed 文献 · Clin Radiol · 2023-04-22

该回顾性研究纳入莱斯特大学医院NHS信托乳腺中心2年间(2020年1月至2022年1月)乳腺MRI检出的95个「二次查看」病灶,基于边缘、T2信号、内部强化模式、对比剂动力学和弥散加权成像模式建立评分系统,以评分≥2分作为活检指征可100%识别恶性病灶,并使超过30%的病灶避免活检。

要点

  • MRI「二次查看」病灶中52%经组织病理学证实为恶性。
  • 恶性病灶最常见对比剂动力学为平台型,其次为廓清型;良性病灶最常见为渐进型。
  • 该中心良恶性鉴别的ADC截断值为1.1×10⁻³ mm²/s。

核心结论

  • 所建议的评分系统可使超过30%的MRI检出「二次查看」病灶避免活检,且未遗漏任何恶性病灶。

研究设计与样本

  • 回顾性研究,纳入莱斯特大学医院NHS信托乳腺中心2年间(2020年1月至2022年1月)乳腺MRI检出的95个「二次查看」病灶,依据边缘、T2信号、内部强化模式、对比剂动力学和弥散加权成像模式进行评估。

关键影像表现/征象

  • 恶性病灶中最常见的对比剂动力学为平台型,其次为廓清型。
  • 良性病灶中最常见的对比剂动力学为渐进型。
  • 基于边缘、T2信号、内部强化模式、对比剂动力学和弥散加权成像模式的特征,提出评分系统以帮助鉴别良恶性「二次查看」病灶。

诊断标准与关键数值

  • 该中心区分良恶性病灶的ADC截断值为1.1×10⁻³ mm²/s。
  • 以评分≥2分作为活检指征,识别恶性病灶的可靠性为100%。
  • 以评分≥2分作为活检指征,可使超过30%的病灶避免活检。

临床应用与阅片要点

  • 基于边缘、T2信号、内部强化模式、对比剂动力学和弥散加权成像模式的多参数评估可用于鉴别MRI检出的「二次查看」乳腺病灶。
  • 评分≥2分作为活检指征在本研究中100%识别恶性病灶,并使超过30%的病灶避免活检。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To propose a scoring system made of reproducible and objective criteria to aid in differentiating malignant from benign "second-look" breast lesions detected at magnetic resonance imaging (MRI).

MATERIALS AND METHODS: Data were collected retrospectively for "second-look" lesions identified on breast MRI studies performed at the University Hospitals of Leicester NHS Trust breast unit over a 2-year period (from January 2020 to January 2022). Ninety-five "second look" MRI-detected lesions were included in this retrospective study. Lesions were assessed according to margins, T2 signal, internal enhancement patterns, contrast kinetics, and diffusion-weighted imaging (DWI) patterns.

RESULTS: Fifty-two per cent of the included lesions were confirmed at histopathology to be malignant. The most common contrast kinetics identified in malignant lesions was the plateau pattern followed by the washout pattern while the most common pattern in benign lesions was the progressive pattern. The apparent diffusion coefficient (ADC) cut-off value for separating benign and malignant lesions at the unit was found to be 1.1 × 10-3 mm2/s. Based on the MRI features described above, a scoring system is suggested to help differentiate benign from malignant "second-look" lesions. According to the present results, setting a score of 2 or more points as an indication for biopsy was 100% reliable in identifying malignant lesions and avoiding biopsies in >30% of lesions.

CONCLUSION: The suggested scoring system could avoid biopsy of >30% of the "second-look" lesions detected by MRI without missing any malignant lesions.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Ziada, Siu, Qassid, et al. A new scoring system for differentiating malignant from benign "second-look" breast lesions detected by MRI in patients with known breast cancer. Clin Radiol. 2023. PMID: 37156710. doi:10.1016/j.crad.2023.03.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。